COVID-19 vaccine reactogenicity in persons with multiple sclerosis

被引：0

作者：

Briggs, F. ^{[1
]}

Mateen, F. ^{[2
]}

Schmidt, H. ^{[3
]}

Currie, K. ^{[4
]}

Siefers, H. ^{[5
]}

Crouthamel, S. ^{[6
]}

Bebo, B. ^{[7
]}

Fiol, J. ^{[8
]}

Racke, M. ^{[9
]}

O'Connor, K. ^{[10
,11
]}

Kolaczkowski, L. ^{[12
]}

Klein, P. ^{[13
]}

McBurney, R. ^{[3
]}

Loud, S. ^{[3
]}

机构：

[1] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA

[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

[3] Accelerated Cure Project MS, Waltham, MA USA

[4] Currie Consultancy Agcy LLC, Eastover, SC USA

[5] Int AIDS Vaccine Initiat, Frederick, MD USA

[6] Mammoth Hosp, Mammoth Lakes, CA USA

[7] Natl Multiple Sclerosis Soc USA, Portland, OR USA

[8] Natl Multiple Sclerosis Soc USA, Bel Air, CA USA

[9] Quest Diagnost, Med Affairs, Secaucus, NJ USA

[10] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA

[11] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA

[12] iConquerMS, Beavercreek, OH USA

[13] iConquerMS, Waltham, MA USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P944

引用

页码：768 / 769

页数：2

共 50 条

[1] COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis
Briggs, Farren Basil Shaw
Mateen, Farrah J.
Schmidt, Hollie
Currie, Keisha M.
Siefers, Heather M.
Crouthamel, Slavka
Bebo, Bruce F.
Fiol, Julie
Racke, Michael K.
O'Connor, Kevin C.
Kolaczkowski, Laura G.
Klein, Phyllis
Loud, Sara
McBurney, Robert Nicholas
[J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (01):
[2] Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Patricia K. Coyle
Anne Gocke
Megan Vignos
Scott D. Newsome
[J]. Advances in Therapy, 2021, 38 : 3550 - 3588
[3] COVID-19 Vaccine Response in People with Multiple Sclerosis
Tallantyre, Emma C.
Vickaryous, Nicola
Anderson, Valerie
Asardag, Aliye Nazli
Baker, David
Bestwick, Jonathan
Bramhall, Kath
Chance, Randy
Evangelou, Nikos
George, Katila
Giovannoni, Gavin
Godkin, Andrew
Grant, Leanne
Harding, Katharine E.
Hibbert, Aimee
Ingram, Gillian
Jones, Meleri
Kang, Angray S.
Loveless, Samantha
Moat, Stuart J.
Robertson, Neil P.
Schmierer, Klaus
Scurr, Martin J.
Shah, Sita Navin
Simmons, Jessica
Upcott, Matthew
Willis, Mark
Jolles, Stephen
Dobson, Ruth
[J]. ANNALS OF NEUROLOGY, 2022, 91 (01) : 89 - 100
[4] Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Coyle, Patricia K.
Gocke, Anne
Vignos, Megan
Newsome, Scott D.
[J]. ADVANCES IN THERAPY, 2021, 38 (07) : 3550 - 3588
[5] Individuals with Multiple Sclerosis' Experience with the COVID-19 Vaccine
Baker, S.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 71 - 71
[6] COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
Iyer, Rajesh B.
Raghavendra, S.
Nooraine, Javeria M.
Jaychandran, R.
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
[7] COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis
Abbasi, Naghmeh
Ghadiri, Fereshteh
Moghadasi, Abdorreza Naser
Azimi, Amirreza
Navardi, Samira
Heidari, Hora
Karaminia, Maryam
Sahraian, Mohammad Ali
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
[8] Overcoming COVID-19 vaccine hesitancy in people with multiple sclerosis
Kalron, A.
Dolev, M.
Menascu, S.
Aloni, R.
Frid, L.
Givon, U.
Magalashvilli, D.
Achiron, A.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 218 - 218
[9] Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Patricia K. Coyle
Anne Gocke
Megan Vignos
Scott D. Newsome
[J]. Advances in Therapy, 2022, 39 : 822 - 830
[10] Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine
Fyfe I.
[J]. Nature Reviews Neurology, 2021, 17 (10) : 595 - 595

← 1 2 3 4 5 →